{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:34:52Z","timestamp":1765294492414},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2011,4,28]],"date-time":"2011-04-28T00:00:00Z","timestamp":1303948800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0019115","type":"journal-article","created":{"date-parts":[[2011,4,28]],"date-time":"2011-04-28T21:21:01Z","timestamp":1304025661000},"page":"e19115","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":44,"title":["Serum Levels of Adipocyte Fatty Acid-Binding Protein Are Associated with the Severity of Coronary Artery Disease in Chinese Women"],"prefix":"10.1371","volume":"6","author":[{"given":"Yuqian","family":"Bao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhigang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huating","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meifang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiping","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,4,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1210\/jc.2004-0395","article-title":"Adipose tissue as an endocrine organ.","volume":"89","author":"EE Kershaw","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2464S","DOI":"10.1093\/jn\/134.9.2464S","article-title":"Fatty acid binding proteins\u2013the evolutionary crossroads of inflammatory and metabolic responses.","volume":"134","author":"L Makowski","year":"2004","journal-title":"J Nutr"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00041433-200204000-00005","article-title":"Cytoplasmic fatty acid-binding proteins: emerging roles in metabolism and atherosclerosis.","volume":"13","author":"JB Boord","year":"2002","journal-title":"Curr Opin Lipidol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1126\/science.274.5291.1377","article-title":"Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein.","volume":"274","author":"GS Hotamisligil","year":"1996","journal-title":"Science"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1210\/endo.141.9.7637","article-title":"Improved glucose and lipid metabolism in genetically obese mice lacking aP2.","volume":"141","author":"KT Uysal","year":"2000","journal-title":"Endocrinology"},{"key":"ref6","first-page":"2640","article-title":"Adipocyte\/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice.","volume":"118","author":"M Furuhashi","year":"2008","journal-title":"J Clin Invest"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/89076","article-title":"Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis.","volume":"7","author":"L Makowski","year":"2001","journal-title":"Nature Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1161\/01.ATV.0000033090.81345.E6","article-title":"Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia.","volume":"22","author":"JB Boord","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/nature05844","article-title":"Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2.","volume":"447","author":"M Furuhashi","year":"2007","journal-title":"Nature"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"6970","DOI":"10.1073\/pnas.0602178103","article-title":"A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease.","volume":"103","author":"G Tuncman","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1373\/clinchem.2005.062463","article-title":"Adipocyte fatty acid-binding protein is a plasmabiomarker closely associated with obesity and metabolic syndrome.","volume":"52","author":"A Xu","year":"2006","journal-title":"Clin Chem"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1161\/ATVBAHA.107.146274","article-title":"Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis in Chinese women.","volume":"27","author":"DCY Yeung","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1530\/EJE-08-0665","article-title":"The association of serum adipocyte fatty acid-binding protein with coronary artery disease in Korean adults.","volume":"160","author":"EJ Rhee","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.cca.2010.07.031","article-title":"Serum adipocyte fatty acid binding proteins and adiponectin in patients with coronary artery disease: the significance of A-FABP\/adiponectin ratio.","volume":"411","author":"J Jin","year":"2010","journal-title":"Clin Chim Acta"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.","volume":"15","author":"KG Alberti","year":"1998","journal-title":"Diabet Med"},{"key":"ref16","first-page":"390","article-title":"[Chinese guidelines on prevention and treatment of dyslipidemia in adults].","volume":"35","year":"2007","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0033-8389(22)02831-7","article-title":"Percutaneous transfemoral selective coronary arteriography.","volume":"6","author":"MP Judkins","year":"1968","journal-title":"Radiol Clin North Am"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1161\/01.CIR.64.6.1174","article-title":"Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease.","volume":"64","author":"R Tatami","year":"1981","journal-title":"Circulation"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.","volume":"28","author":"DR Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine.","volume":"16","author":"DW Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.106.647503","article-title":"Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study.","volume":"115","author":"A Xu","year":"2007","journal-title":"Circulation"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.2337\/dc07-0413","article-title":"Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort.","volume":"30","author":"AW Tso","year":"2007","journal-title":"Diabetes Care"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cmet.2004.12.008","article-title":"Adipocyte\/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes.","volume":"1","author":"K Maeda","year":"2005","journal-title":"Cell Metab"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrd2589","article-title":"Fatty acid-binding proteins: role in metabloic diseases and potential as drug targets.","volume":"7","author":"M Furuhashi","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1001\/jama.288.21.2709","article-title":"The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.","volume":"288","author":"HM Lakka","year":"2002","journal-title":"JAMA"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"12888","DOI":"10.1074\/jbc.M413788200","article-title":"The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity.","volume":"280","author":"L Makowski","year":"2005","journal-title":"J Biol Chem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/34178","article-title":"The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation.","volume":"391","author":"M Ricote","year":"1998","journal-title":"Nature"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nm820","article-title":"Reciprocal regulation of inflammation and lipid metabolism by liver X receptors.","volume":"9","author":"SB Joseph","year":"2003","journal-title":"Nat Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.atherosclerosis.2010.01.032","article-title":"Serum adipocyte fatty acid-binding protein is independently associated with coronary atherosclerotic burden measured by intravascular ultrasound.","volume":"211","author":"T Miyoshi","year":"2010","journal-title":"Atherosclerosis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1373\/clinchem.2004.034272","article-title":"Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited.","volume":"50","author":"JP Goetze","year":"2004","journal-title":"Clin Chem"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/qjmed\/hci111","article-title":"B-type natriuretic peptide: a simple new test to identify coronary artery disease?","volume":"98","author":"AD Struthers","year":"2005","journal-title":"QJM"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1161\/CIRCRESAHA.109.200501","article-title":"Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease.","volume":"105","author":"V Lamounier-Zepter","year":"2009","journal-title":"Circ Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.0000053730.47739.3C","article-title":"Clinical application of C-reactive protein for cardiovascular disease detection and prevention.","volume":"107","author":"PM Ridker","year":"2003","journal-title":"Circulation"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1161\/01.CIR.102.18.2165","article-title":"Direct proinflammatory effect of C-reactive protein on human endothelial cells.","volume":"102","author":"V Pasceri","year":"2000","journal-title":"Circulation"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1161\/01.CIR.0000052617.91920.FD","article-title":"C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis.","volume":"107","author":"S Devaraj","year":"2003","journal-title":"Circulation"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1365-2265.2008.03277.x","article-title":"Serum levels of adipocyte fatty acid-binding protein (AFABP) are increased in chronic haemodialysis (CD).","volume":"69","author":"G Sommer","year":"2008","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0019115","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T12:02:46Z","timestamp":1712404966000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0019115"}},"subtitle":[],"editor":[{"given":"Aimin","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,4,28]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2011,4,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0019115","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,28]]}}}